Digestive tract motility enhancement

Digestive tract motility enhancement refers to interventions that increase the coordinated contractions and effectiveness of muscular movement throughout the gastrointestinal tract, including the stomach, small intestine, and colon. This process is crucial for efficient mixing of food with digestive secretions, promoting absorption, and propelling contents toward the rectum for eventual elimination. Therapeutic enhancement of GI motility is achieved via modulation of neurotransmitter release (such as acetylcholine or serotonin), stimulation of receptors like the motilin or 5-HT4 receptor, and targeting hormones or interstitial cells that coordinate the muscular syncytium. This is relevant for disorders where natural motility is impaired, such as gastroparesis or chronic constipation. However, 'digestive tract motility enhancement' is a functional outcome, not a distinct molecular target, and encompasses multiple molecular targets and pathways[1][2][4][5][6].

Other names

GI motility enhancementGastrointestinal motility promotionProkinetic effect

Stimulation of enteric nervous system (acetylcholine release, serotonin activation); Activation of specific receptors (e.g. motilin receptor, 5-HT4 receptor); Smooth muscle contraction via Ca2+ influx and myosin phosphorylation; Inhibition of inhibitory neurotransmitters or hormones (such as somatostatin or CGRP)